Previous studies have reported some biomarkers related to cancer immunotherapeutic response such as TMB and the expression of some critical immune checkpoint genes [27,40], so we further explored the association of CD8A with TMB and critical immune checkpoint genes. This evidence concerns the gene CD8A and cancer.